$0.22 Earnings Per Share Expected for Surgery Partners Inc (NASDAQ:SGRY) This Quarter

Brokerages expect Surgery Partners Inc (NASDAQ:SGRY) to post $0.22 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Surgery Partners’ earnings. Surgery Partners posted earnings of ($0.74) per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 129.7%. The company is expected to announce its next earnings results on Wednesday, March 11th.

On average, analysts expect that Surgery Partners will report full-year earnings of ($0.77) per share for the current financial year. For the next year, analysts forecast that the company will report earnings of ($0.14) per share. Zacks’ EPS averages are a mean average based on a survey of research analysts that that provide coverage for Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, November 5th. The company reported ($0.28) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.34) by $0.06. The business had revenue of $452.00 million during the quarter, compared to the consensus estimate of $452.30 million. Surgery Partners had a negative net margin of 11.26% and a negative return on equity of 5.32%. Surgery Partners’s revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.19) earnings per share.

A number of research firms recently weighed in on SGRY. Zacks Investment Research raised shares of Surgery Partners from a “hold” rating to a “buy” rating and set a $16.00 price target for the company in a research note on Saturday. ValuEngine downgraded shares of Surgery Partners from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. BidaskClub raised shares of Surgery Partners from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, November 12th. Finally, Citigroup boosted their price target on shares of Surgery Partners from $13.00 to $20.00 and gave the stock a “buy” rating in a research note on Tuesday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $16.00.

A number of large investors have recently modified their holdings of the business. Millennium Management LLC increased its stake in Surgery Partners by 5,528.2% in the third quarter. Millennium Management LLC now owns 652,631 shares of the company’s stock valued at $4,819,000 after purchasing an additional 664,654 shares in the last quarter. Squarepoint Ops LLC increased its stake in Surgery Partners by 96.0% in the third quarter. Squarepoint Ops LLC now owns 95,758 shares of the company’s stock valued at $707,000 after purchasing an additional 46,891 shares in the last quarter. Barclays PLC increased its stake in Surgery Partners by 21.6% in the third quarter. Barclays PLC now owns 19,294 shares of the company’s stock valued at $143,000 after purchasing an additional 3,432 shares in the last quarter. State Street Corp increased its stake in Surgery Partners by 20.0% in the third quarter. State Street Corp now owns 448,935 shares of the company’s stock valued at $3,315,000 after purchasing an additional 74,930 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in Surgery Partners by 8.7% in the third quarter. Rhumbline Advisers now owns 34,402 shares of the company’s stock valued at $254,000 after purchasing an additional 2,763 shares in the last quarter. 96.05% of the stock is owned by hedge funds and other institutional investors.

Shares of SGRY traded down $0.30 on Friday, reaching $14.96. 164,739 shares of the company’s stock were exchanged, compared to its average volume of 288,449. The company has a current ratio of 1.36, a quick ratio of 1.24 and a debt-to-equity ratio of 2.39. The stock has a market capitalization of $714.38 million, a P/E ratio of -6.11 and a beta of 2.65. The business has a 50 day moving average price of $11.32 and a two-hundred day moving average price of $8.51. Surgery Partners has a 12 month low of $5.38 and a 12 month high of $15.33.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also: What is a conference call?

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.